Cargando…
Non‐erythropoietic erythropoietin‐derived peptide protects mice from systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease, which results in various organ pathologies. However, current treatment towards SLE is suboptimal. Erythropoietin (EPO) has been shown to promote SLE recovery, but clinical application can be limited by its haematopoiesis‐stimulating effect...
Autores principales: | Huang, Bo, Jiang, Juntao, Luo, Bangwei, Zhu, Wen, Liu, Yuqi, Wang, Zhishang, Zhang, Zhiren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010693/ https://www.ncbi.nlm.nih.gov/pubmed/29570934 http://dx.doi.org/10.1111/jcmm.13608 |
Ejemplares similares
-
Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection
por: Liu, Yuqi, et al.
Publicado: (2014) -
Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance
por: Liu, Yuqi, et al.
Publicado: (2015) -
Erythropoietin and Non-Erythropoietic Derivatives in Cognition
por: Newton, Samuel S., et al.
Publicado: (2021) -
Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration
por: Colella, Pasqualina, et al.
Publicado: (2011) -
Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
por: Nguyen, Ly M., et al.
Publicado: (2018)